Immunotargeting of liposomes containing lipophilic antitumor prodrugs.
Immunotargeting of liposomes containing lipophilic antitumor prodrugs.
复制标题
含有亲脂性抗肿瘤前药的脂质体的免疫靶向。
DOI:
10.1023/a:1018933632318
复制
发表时间:
1993
影响因子:
3.7
通讯作者:
Huang,L
中科院分区:
文献类型:
--
作者:
Mori,A;Kennel,SJ;Huang,L
Potential therapeutic applications of recently developed liposomes with a reduced affinity to the reticuloendothelial systems and a prolonged circulation time as targeting systems for lipophilic prodrugs were examined. In these studies, liposomes composed of phosphatidylcholine and cholesterol, additionally containing monosialoganglioside (GM1) or polyethylene glycol conjugated to phosphatidyl-ethanolamine (PEG-PE), were used. Three antitumor lipophilic prodrugs,N-trifluoroacetyl-adriamycin-14-valerate (AD32), araC-diphosphate-diglyceride (araCdPdG), and 3′,5′-o-dipalmitoyl-5-fluoro-2′-deoxyuridine (dpFUdR), were used to examine the effect of lipophilic prodrug incorporation into long-circulating liposomes and immunoliposomes on their biodistribution in mouse. Biodistribution studies with antibody-free liposomes containing lipophilic prodrugs showed that the activities of GM1or PEG2000-PE in prolonging the circulation time of liposomes appeared to be preserved in the presence of each of the three lipophilic prodrugs at a drug/lipid molar ratio of 3:97. The effect of lipophilic prodrug incorporation on target binding of immunoliposomes was then examined using a mouse model. Incorporation of AD32 or dpFUdR into immunoliposomes, directed to the normal endothelium, did not affect the targetability of immunoliposomes, suggesting a potential effectiveness of these lipophilic prodrug-containing immunoliposomes in therapy for lung tumors. On the contrary, incorporation of araCdPdG resulted in significantly reduced target binding of immunoliposomes by yet unknown mechanism(s).
登录
查看更多内容
DOI:
--
发表时间:
2004
期刊:
Cancer Immunology and Immunotherapy
影响因子:
--
作者:
P. Brusa;F. Pietribiasi;G. Bussolati;F. Dosio;R. Arione;P. Comoglio;M. Prat;L. Cattel
通讯作者:
L. Cattel
影响因子:
3.8
作者:
T. Shinoda;Akira Takagi;Atsushi Maeda;S. Kagatani;Y. Konno;M. Hashida
通讯作者:
M. Hashida
DOI:
--
发表时间:
2005
期刊:
Cancer Immunology and Immunotherapy
影响因子:
--
作者:
P. Brusa;F. Dosio;F. Pietribiasi;L. Delprino;Paola Feraiorni;M. Mariani;G. Bussolati;L. Cattel
通讯作者:
L. Cattel
影响因子:
1.7
作者:
Y. Tokunaga;T. Iwasa;J. Fujisaki;S. Sawai;A. Kagayama
通讯作者:
A. Kagayama
影响因子:
7.2
作者:
Chaurasiya, Shyambabu;Yang, Annie;Fong, Yuman
通讯作者:
Fong, Yuman